SCHEMBL7010571

SCHEMBL7010571

Nc1cc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(N)C4)cc32)c(Cl)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 4/20 0.49
CYP2C9 P11712 2/20 0.49
CYP3A4 P08684 1/20 0.49
LMNA P02545 5/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 7/20 0.46
KDM4E B2RXH2 5/20 0.46
HPGD P15428 4/20 0.46
HSD17B10 Q99714 4/20 0.46
TOP2A P11388 4/20 0.44
TOP2B Q02880 2/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
DRD3 P35462 1/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8484204 0.93 TOP1 (0.58) TOP1LMNAKMT2AMEN1ALDH1A1
SCHEMBL7007766 0.93 TOP1 (0.58) TOP1LMNAKMT2AMEN1ALDH1A1
SCHEMBL7013177 0.92 LMNA (0.50) TOP1CYP2C9CYP3A4LMNAKMT2A
SCHEMBL8481317 0.86 ALDH1A1 (0.65) TOP1CYP2C9LMNAKMT2AMEN1
SCHEMBL7012178 0.86 TOP1 (0.43) TOP1CYP2C9CYP3A4LMNAKMT2A
SCHEMBL8482062 0.85 TOP1 (0.59) TOP1CYP2C9LMNAKMT2AMEN1
SCHEMBL7009374 0.85 TOP1 (0.59) TOP1CYP2C9LMNAKMT2AMEN1
SCHEMBL7004281 0.85 TOP1 (0.45) TOP1CYP2C9CYP3A4LMNAKMT2A
SCHEMBL7004810 0.83 CYP3A4 (0.68) TOP1CYP2C9CYP3A4ALDH1A1TOP2A
SCHEMBL7013070 0.83 KMT2A (0.60) TOP1CYP2C9CYP3A4LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0787720-B1 PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KK (JP) 2003-07-16 EP disclosed
US-5910498-A NOVEL COMPOUNDS HAVING REDUCED CYTOTOXICITY, PHOTOTOXICITY; TREATING BACTERIAL AND VIRAL INFECTIONS WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1999-06-08 US disclosed
EP-0787720-A1 NOVEL PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1997-08-06 EP disclosed